NCT00346294 An Open-Label Study to Assess the Rate of Failure of an Enbrel® (Etanercept) SureClick™ Auto-injector in Subjects With Rheumatoid Arthritis Status COMPLETED Phase PHASE4
NCT00346099 Study of Panitumumab Given First With Capecitabine and Oxaliplatin (CAPOX) and Then With Capecitabine and Radiation of the Pelvis for Treatment of Patients With Rectal Cancers That May or May Not Have Spread Beyond the Rectum Status WITHDRAWN Phase PHASE2
NCT00345839 E.V.O.L.V.E. Trial™: EValuation Of Cinacalcet Hydrochloride (HCl) Therapy to Lower CardioVascular Events Status COMPLETED Phase PHASE3
NCT00339183 Comparison of Treatment Effect of Chemotherapy With Panitumumab to Chemotherapy Alone Status COMPLETED Phase PHASE3
NCT00333034 Study Evaluating the Safety and Efficacy of Etanercept 50 mg Once Weekly in Subjects With Psoriasis Status COMPLETED Phase PHASE3
NCT00332332 Canadian Assessment of Patient Outcomes and Effectiveness of Etanercept (Enbrel) in Psoriasis Status COMPLETED Phase PHASE4
NCT00332163 Skin Toxicity Treatment in Metastatic Colorectal Cancer (mCRC) Patients Receiving Panitumumab + Irinotecan-based Therapy Status COMPLETED Phase PHASE2
NCT00330759 Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma. Status COMPLETED Phase PHASE3
NCT00330460 A Randomized, Double-Blind Study to Compare the Efficacy of Treatment With Denosumab Versus Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density. Status COMPLETED Phase PHASE3
NCT00327119 Phase 2 Study of ABX-EGF (Panitumumab) in Japanese Subjects With M-colorectal Cancer Status COMPLETED Phase PHASE2
NCT00325468 An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety of Denosumab Administration in Postmenopausal Women With Low Bone Mineral Density Status COMPLETED Phase PHASE3
NCT00322439 Observational Safety Study of Etanercept (Enbrel) for Treatment of Psoriasis Status COMPLETED Phase N/A
NCT00322400 Phase1b to Evaluate Safety of AMG706 in Combination With Paclitaxel or Docetaxel for Breast Cancer Status COMPLETED Phase PHASE1
NCT00321711 Determination of Safe and Effective Dose of Romiplostim (AMG 531) in Subjects With Myelodysplastic Syndrome (MDS)Receiving Hypomethylating Agents Status COMPLETED Phase PHASE2
NCT00321620 Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Men With Hormone-refractory Prostate Cancer Status COMPLETED Phase PHASE3
NCT00321464 A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects. Status COMPLETED Phase PHASE3
NCT00317499 Double-blind, Randomized, Placebo-controlled Phase 3 Study of Etanercept in the Treatment of Psoriatic Arthritis and Psoriasis Status COMPLETED Phase PHASE3
NCT00314977 Sequential vs Upfront Intensified Neoadjuvant Chemotherapy in Patients With Large Resectable or Locally Advanced Breast Cancer. Status COMPLETED Phase PHASE3
NCT00309556 Randomized Neoadjuvant Study of Epirubicin and Docetaxel With/Without Capecitabine in Early Breast Cancer Status COMPLETED Phase PHASE3
NCT00306215 A Study to Evaluate the Efficacy and Safety of CCX282-B in Subjects With Moderate to Severe Crohn's Disease Status COMPLETED Phase PHASE2